FDA Finalizes Rule on Nonprescription Drug Products With Additional Conditions for Use
December 25, 2024
December 25, 2024
WASHINGTON, Dec. 25 (TNSFR) -- The Food and Drug Administration (FDA) has issued a final rule to establish requirements for nonprescription drug products with an additional condition for nonprescription use (ACNU). This regulatory framework enables certain drugs, previously requiring a prescription, to be marketed without one if specific conditions are met to ensure safe and effective use by consumers.
The new rule aims to expand consumer access to safe and effective medications, po . . .
The new rule aims to expand consumer access to safe and effective medications, po . . .